Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1)-Reference-Cited by-同舟云学术

Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1)

Published:2009-09-10 Issue:3 Volume:221 Page:778-788
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Pereira Barry P.,Zhou Yefang,Gupta Anurag,Leong David T.,Aung Khin Zarchi,Ling Ling,Pho Robert W.H.,Galindo Mario,Salto-Tellez Manuel,Stein Gary S.,Cool Simon M.,van Wijnen Andre J.,Nathan Saminathan S.

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference51 articles.

1. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin;Bacci;Cancer,1993

2. Preoperative chemotherapy for osteosarcoma with intravenous Adriamycin and intoa-arterial cis-platinum;Beijamin;Ann Oncol Suppl,1992

3. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage;Berman;Proc Natl Acad Sci USA,2008a

4. The retinoblastoma protein tumor suppressor is important for appropriate osteoblast differentiation and bone development;Berman;Mol Cancer Res,2008b

5. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols;Bielack;J Clin Oncol,2002

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility and barriers to rapid establishment of patient-derived primary osteosarcoma cell lines in clinical management;iScience;2024-09

2. Collagen type X expression and chondrocyte hypertrophic differentiation during OA and OS development;American Journal of Cancer Research;2024

3. Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma;Cells;2023-12-21

4. Gossypetin Is a Novel Modulator of Inflammatory Cytokine Production and a Suppressor of Osteosarcoma Cell Growth;Antioxidants;2023-09-10

5. ETC-159, an Upstream Wnt inhibitor, Induces Tumour Necrosis via Modulation of Angiogenesis in Osteosarcoma;International Journal of Molecular Sciences;2023-03-01